Validation of the RosaQol scale in Colombia for assessing the quality of life of patients with rosacea in Bogotá
DOI:
https://doi.org/10.29176/2590843X.2035Keywords:
Rosacea, quality of life, validation, cultural, Cross cultural adaptationAbstract
Introduction: Rosacea is a common chronic recurrent inflammatory skin condition that mainly affects the central part of the face. Although not life-threatening, rosacea is associated with significant psychosocial morbidity, with reports of people with rosacea reporting increased depression and anxiety that can negatively affect routine daily activities. RosaQol is an internationally validated tool that allows measuring the specific effects on the quality of life in patients with rosacea. The article discusses what is related to the validation of the RosaQol scale.
Methods: This is a validation study of the measurement scale in health, 105 patients diagnosed with rosacea over 18 years of age were included and several stages were determined, including the selection of the scale, translation, preliminary test, validity tests, reliability tests and determination of its usefulness.
Results: 105 surveys were analyzed and it was concluded that Cronbach's alpha test was reliable, a coefficient value of 0.849 was calculated, which is considered acceptable as it is between 0.7 and 0.9.
Conclusion: RosaQol, showed in its translation and validation its consistency, correlation and reliability for our Colombian population. These findings allow the use of this version to assess the impact of quality of life.
Author Biographies
Juliana Pinzon-Luna, Universidad El Bosque, Bogotá, Colombia
Residente de Dermatología, Universidad El Bosque, Bogotá, Colombia.
Martha Liliana Duque, Universidad El Bosque, Bogotá, Colombia
Dermatóloga, Universidad El Bosque, Bogotá, Colombia.
Andrés Felipe García, Universidad El Bosque, Bogotá, Colombia
Dermatólogo, Universidad El Bosque, Bogotá, Colombia.
Ana M Sarmiento-Ruiz, Universidad El Bosque, Bogotá, Colombia
Residente de Dermatología, Universidad El Bosque, Bogotá, Colombia.
Lili Rueda Jaime, Universidad El Bosque. Bogotá, Colombia
Dermatóloga, Grupo de Investigación. Dermatología Clínica e Infecciosa. Universidad El Bosque. Bogotá, Colombia.
Edgar Ibañez, Universidad El Bosque, Bogotá, Colombia
Docencia Posgrado en Dermatología, Universidad El Bosque, Bogotá, Colombia.
Adriana Motta Beltran, Universidad El Bosque, Bogotá, Colombia
Dermatóloga, Hospital Simón Bolívar. Directora de Posgrado en Dermatología, Universidad El Bosque, Bogotá, Colombia
References
Rueda LJ, Motta A, Pabón JG, Barona MI, Meléndez E, Orozco B, et al. Epidemiology of rosacea in Colombia. Int J Dermatol. Mayo de 2017;56(5):510-3.
Van Zuuren EJ. Rosacea. Solomon CG, editor. N Engl J Med. 2 de noviembre de 2017;377(18):1754-64.
Anzengruber F, Czernielewski J, Conrad C, Feldmeyer L, Yawalkar N, Häusermann P, et al. Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol. noviembre de 2017;31(11):1775-91.
van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: New Concepts in Classification and Treatment. Am J Clin Dermatol. 2021 Jul;22(4):457-465.
van der Linden MM, van Rappard DC, Daams JG, Sprangers MA, Spuls PI, de Korte J. Health-related quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol. 2015 Apr;95(4):395-400.
Tan J, Almeida LMC, Bewley A, Cribier B, Dlova NC, Gallo R, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSasea COnsensus (ROSCO) panel. Br J Dermatol. febrero de 2017;176(2):431-8.
van der Linden MMD, van Ratingen AR, van Rappard DC, Nieuwenburg SA, Spuls PhI. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety. Br J Dermatol. junio de 2017;176(6):1465-74.
Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality- of-lifeinstrument for acne rosacea. J Am Acad Dermatol. 2007 Aug;57(2):213-21. https://doi.org/10.1016/j.jaad.2007.01.048. Epub 2007 Apr 18. PMID: 17445948.
Tannus FC, Picosse FR, Soares JM, Bagatin E. Rosacea-specific quality of life questionnaire: translation, cultural adaptation and validation for Brazilian Portuguese. A Bras Dermatol. 2018 Nov/Dec;93(6):836-842. https://doi.org/10.1590/abd1806-4841.20187192. PMID: 30484528; PMCID: PMC6256224.
Deng Y, Peng Q, Yang S, Jian D, Wang B, Huang Y, et al. (2018) The Rosacea- specific Quality-of-Life instrument (RosQol): Revision and validation among Chinese patients. PLoS ONE 13(2):e0192487. https://doi.org/10.1371/journal.pone.0192487.
Sánchez R, Echeverry J. Validación de escalas de medición en salud. Rev salud pública [Internet]. noviembre de 2004 [citado 6 de noviembre de 2020];6(3). Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0124-00642004000300006&lng=es&nrm=iso&tlng=es.
Taherdoost H. Validity and reliability of the research instrument; how to test the validation of a questionnaire/survey in a research. How to Test the Validation of a Questionnaire/Survey in a Research (August 10, 2016). 2016 Aug 10.
Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. Journal of the American Academy of Dermatology. enero de 2018;78(1):148-55
Marson JW, Baldwin HE. Rosacea: a wholistic review and update from pathogenesis to diagnosis and therapy. International journal of dermatology. 2020 Jun;59(6):e175- 82.
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Juliana Pinzon-Luna, Martha Liliana Duque, Andrés Felipe García, Ana M Sarmiento-Ruiz, Lili Rueda Jaime, Edgar Ibañez, Adriana Motta Beltran
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
